Type 1 Diabetes News

The landmark Diabetes Control and Complications Trial showed conclusively that tight blood glucose control significantly reduces the risk of developing complications of diabetes such as eye, kidney and nerve disease. But the DCCT also showed that tight control -- achieved by taking three or more insulin injections daily -- can come at a cost.

Researchers have developed a novel technique to deliver insulin genes to the pancreas, the organ that produces the body's insulin. This approach is a major step in the potential treatment of Type I diabetes since patients with the disease do not produce enough insulin on their own.

A new mechanism for the formation of insulin crystals in the pancreas has been discovered.

A major finding, which represents an important step toward a potential cure for type 1 (insulin-dependent) diabetes, has been made.

Researchers have now carefully crafted a combination therapy that reverses recent-onset type 1 diabetes in 2 models of disease.

Results of a new study support the hypothesis that periodontal therapy may improve metabolic control (lower HbA1c) in diabetic patients.

Disetronic announced a voluntary nationwide recall of all ACCU-CHEK Ultraflex Infusion Sets because of a potential that tubing could fully or partially separate at the luer lock-tubing connection.

Islet cell xenotransplantation presents a promising near-term solution to the critically low islet cell supply for humans suffering from type 1 diabetes.

People with diabetes are twice as likely as the general population to develop depression. For the first time, doctors have reason to ask if the increased risk of depression could in fact be due to changes in brain.

In this study, the authors looked at rates of amputation among close to 100,000 patients with diabetes mellitus and found that height was a strong predictor of amputation.

There is a new, potential alternative for many of the more than 5 million Americans who take insulin injections, with the Food and Drug Administration's approval today of the first ever inhaled insulin.

Researchers are using a new cell transplantation technique to restore the cells that produce insulin in patients with type 1 diabetes.

Potential for life-threatening falsely elevated glucose readings in patients who have received parenteral products containing maltose or galactose, or oral xylose, and are subsequently tested using glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) based glucose monitoring systems.

Patients with type 1 diabetes have an improved prognosis with regard to end-stage renal disease over the past four decades.

The suit asks the Court to compel public school officials to comply with federal law by providing the assistance that California students with diabetes require to manage their diabetes during the school day.

Transplantation of insulin-producing pancreatic beta-cells shows great promise as a treatment for type 1 diabetes.